Sunzen Biotech

SUNZEN

MYQ0148OO005

Food Processing

End-of-day quote BURSA MALAYSIA Other stock markets 06:00:00 2024-06-04 pm EDT			5-day change	1st Jan Change
0.38 ^MYR	-1.30%		-1.30%	+26.67%

May. 24	Sunzen Biotech Berhad Reports Earnings Results for the Third Quarter Ended March 31, 2024	CI
May. 06	Sunzen Biotech Berhad executed a non-binding Term Sheet to acquire 70% stake in Eye Nation Medical Sdn.Bhd from Mr. Lee Peng Hwa and Madam Lay Lee Chin for MYR 6.37 million	CI

Sunzen Biotech Berhad Announces Change in Financial Year End

November 29, 2023 at 07:41 am EST

The Board of Directors of Sunzen Biotech Berhad has approved the change of financial year end of the Company from 31 December to 30 June. Following the change of financial year end, the next set of audited financial statements shall be made up for a period of 18 months from 1 January 2023 to 30 June 2024. The change of financial year end is to ensure timely completion of the annual audit.

Latest news about Sunzen Biotech

Sunzen Biotech Berhad Reports Earnings Results for the Third Quarter Ended March 31, 2024	May. 24	CI
Sunzen Biotech Berhad executed a non-binding Term Sheet to acquire 70% stake in Eye Nation Medical Sdn.Bhd from Mr. Lee Peng Hwa and Madam Lay Lee Chin for MYR 6.37 million	May. 05	CI
Sunzen Biotech Shelves Plans of MYR4.3 Million Stake Acquisition in Farmer International	May. 02	MT
Sunzen Biotech to End Operations of Loss-Making Animal Health Unit	Apr. 09	MT
Sunzen Biotech Berhad Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Sunzen Biotech Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Sunzen Biotech Buys MYR4.3 Million Stake in Farmer International	Jan. 25	MT
Sunzen Biotech Berhad agreed to acquire additional 30% stake in Ecolite Biotech Manufacturing Sdn Bhd from group of sellers for MYR 18.2 million.	Dec. 19	CI
Sunzen Biotech Berhad Announces Change of Address	Dec. 18	CI
Sunzen Biotech Berhad Announces Appointment of Puan Aida Lim Binti Abdullah as Independent and Non Executive Member of Audit Committee	Dec. 01	CI
Sunzen Biotech Berhad Announces Appointment of Aida Lim Binti Abdullah as Independent and Non Executive Member of Nomination Committee	Dec. 01	CI
Sunzen Biotech Berhad Announces Appointment of Puan Aida Lim Binti Abdullah as Independent and Non Executive Independent Director	Dec. 01	CI
Sunzen Biotech Berhad Announces Appointment of Aida Lim Binti Abdullah as Independent and Non Executive Member of Remuneration Committee	Dec. 01	CI
Sunzen Biotech Berhad Announces Change in Financial Year End	Nov. 29	CI
Sunzen Biotech Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
Sunzen Biotech Berhad Announces Resignation of Zeenath Begum Binti Mohamed Mastan as Joint Company Secretary	Nov. 29	CI
Sunzen Biotech Berhad Appoints Cheng Weng Soon as Joint Company Secretary	Nov. 29	CI
Sunzen Biotech Berhad Appoints Lee Yew Weng as Non Independent and Non Executive Member of Nomination Committee	Nov. 01	CI
Sunzen Biotech Berhad Announces Redesignation of Khoo Kien Hoe from Independent and Non Executive Member of Nomination Committee to Independent and Non Executive Chairman of Nomination Committee	Nov. 01	CI
Sunzen Biotech Berhad Appoints Lee Yew Weng as Non Independent and Non Executive Member of Audit Committee	Nov. 01	CI
Sunzen Biotech Berhad Announces Appointment of Lee Yew Weng as Non Independent and Non Executive Member of Remuneration Committee	Nov. 01	CI
Sunzen Biotech Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-30	CI
Sunzen Biotech Berhad Announces Resignation of FONG CHAN SENG as Independent and Non Executive Member of Audit Committee	23-08-04	CI
Sunzen Biotech Berhad Announces the Resignation of Dr. Fong Chan Seng as Independent and Non Executive Director, Member of Remuneration Committee, Chairman of Nomination Committee	23-08-04	CI
Sunzen Biotech Berhad Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-26	CI

Chart Sunzen Biotech

Duration

Period

More charts

Company Profile

Sunzen Biotech Berhad is a Malaysia-based company, which is principally engaged in the businesses of biotechnology research and development, manufacturing and marketing of animal feed supplement products and investment holding. The Company operates through four segments: Manufacturing and trading of animal health products, Trading and processing of crude palm oil and related products, Traditional Chinese medicines and herbal health foods and beverages, and Loan financing. Its products include bird's nest, The Joy of Life collagen drink, Pu Yao Jing tonic, essence of chicken, essence of fish, Pi Pa Gao cough syrup, Bai Foong Wan, food supplements, dried herbs and more. The products are widely distributed to all consumers through retail concept stores in Malaysia as well in Ecolite store online shop. Its subsidiaries include Sunzen Corporation Sdn. Bhd., Sunzen International Sdn. Bhd., Finsource Credit (M) Sdn. Bhd., and Sunzen Lifesciences Sdn. Bhd among others.

Sector

Food Processing

Calendar

2024-08-26 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Food Processing

	1st Jan change	Capi.
SUNZEN BIOTECH	+26.67%	57.19M
NESTLÉ S.A.	+0.50%	286B
MONDELEZ INTERNATIONAL, INC.	-6.14%	91.19B
KRAFT HEINZ	-6.25%	42.1B
DANONE	+1.23%	41.5B
THE HERSHEY COMPANY	+6.39%	40.11B
GENERAL MILLS, INC.	+3.56%	38.08B
ARCHER-DANIELS-MIDLAND COMPANY	-15.44%	30.2B
NESTLÉ INDIA LIMITED	-6.98%	29.01B
ASSOCIATED BRITISH FOODS PLC	+8.66%	24.6B